Sarah Meredith

6.5k total citations · 2 hit papers
65 papers, 4.1k citations indexed

About

Sarah Meredith is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Sarah Meredith has authored 65 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 18 papers in Public Health, Environmental and Occupational Health and 11 papers in Epidemiology. Recurrent topics in Sarah Meredith's work include Tuberculosis Research and Epidemiology (14 papers), Ethics in Clinical Research (8 papers) and Occupational exposure and asthma (7 papers). Sarah Meredith is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Ethics in Clinical Research (8 papers) and Occupational exposure and asthma (7 papers). Sarah Meredith collaborates with scholars based in United Kingdom, United States and Australia. Sarah Meredith's co-authors include Wayne A. Ray, Kathi Hall, J C McDonald, Katherine T. Murray, Andrew Nunn, Purushottam B. Thapa, Victoria M. Taylor, Sally Stenning, Patrick Phillips and Jayne F. Tierney and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Sarah Meredith

60 papers receiving 3.9k citations

Hit Papers

Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive... 2014 2026 2018 2022 2014 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Meredith United Kingdom 29 1.1k 1.0k 772 489 454 65 4.1k
Ferdinand Mugusi Tanzania 41 662 0.6× 1.9k 1.9× 1.4k 1.8× 399 0.8× 258 0.6× 139 5.0k
Timo Klaukka Finland 45 1.5k 1.4× 590 0.6× 1.2k 1.5× 452 0.9× 568 1.3× 146 7.5k
Shlomo Vinker Israel 35 1.2k 1.1× 651 0.6× 729 0.9× 664 1.4× 381 0.8× 230 5.2k
Jean Jacques Noubiap Cameroon 38 667 0.6× 976 1.0× 1.4k 1.8× 447 0.9× 1.3k 3.0× 244 5.3k
Maria Elena Flacco Italy 40 1000 0.9× 541 0.5× 581 0.8× 413 0.8× 441 1.0× 158 3.7k
Matthew D. Ritchey United States 31 544 0.5× 1.8k 1.8× 637 0.8× 310 0.6× 1.3k 2.9× 72 6.1k
Jean‐Marc Tréluyer France 44 1.1k 1.0× 1.8k 1.8× 1.2k 1.6× 612 1.3× 226 0.5× 326 7.3k
Melissa Saul United States 40 340 0.3× 768 0.8× 1.3k 1.7× 956 2.0× 697 1.5× 145 5.5k
Ricardo Sesso Brazil 41 1.0k 1.0× 389 0.4× 826 1.1× 432 0.9× 355 0.8× 211 5.6k
Jean Joël Bigna Cameroon 32 571 0.5× 807 0.8× 1.1k 1.4× 355 0.7× 666 1.5× 123 3.5k

Countries citing papers authored by Sarah Meredith

Since Specialization
Citations

This map shows the geographic impact of Sarah Meredith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Meredith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Meredith more than expected).

Fields of papers citing papers by Sarah Meredith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Meredith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Meredith. The network helps show where Sarah Meredith may publish in the future.

Co-authorship network of co-authors of Sarah Meredith

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Meredith. A scholar is included among the top collaborators of Sarah Meredith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Meredith. Sarah Meredith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fabiane, Stella M., Chen‐Yuan Chiang, Sarah Meredith, et al.. (2024). Comparative Efficacy and Safety of Moxifloxacin and Levofloxacin in a Short Standardised Rifampicin Resistant TB Regimen: A STREAM 2 Secondary Analysis. Tropical Medicine and Infectious Disease. 9(9). 211–211.
4.
Tweed, Conor, Angela M. Crook, Rodney Dawson, et al.. (2019). Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status. BMC Pulmonary Medicine. 19(1). 152–152.
5.
Tweed, Conor, Genevieve H. Wills, Angela M. Crook, et al.. (2018). Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study. BMC Medicine. 16(1). 46–46. 50 indexed citations
6.
Tweed, Conor, Angela M. Crook, Evans Amukoye, et al.. (2018). Toxicity associated with tuberculosis chemotherapy in the REMoxTB study. BMC Infectious Diseases. 18(1). 317–317. 27 indexed citations
7.
Murphy, Michael E., Patrick Phillips, Carl M. Mendel, et al.. (2017). Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis. BMC Medicine. 15(1). 192–192. 8 indexed citations
8.
Anie, Kofi A., Jacky B. Buckton, Mark Layton, et al.. (2016). SWIM (sickle with ibuprofen and morphine) randomised controlled trial fails to recruit: lessons learnt. BMJ Open. 6(6). e011276–e011276. 4 indexed citations
9.
Gillespie, Stephen H., Angela M. Crook, Timothy D. McHugh, et al.. (2014). Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis. New England Journal of Medicine. 371(17). 1577–1587. 401 indexed citations breakdown →
10.
Thomas, Kim S, Karin Koller, Taraneh Dean, et al.. (2011). A multicentre randomised controlled trial and economic evaluation of ion-exchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET). Health Technology Assessment. 15(8). v–vi, 1. 40 indexed citations
11.
Newman, Stanton, Debbie Cooke, Angela Casbard, et al.. (2009). A randomised controlled trial to compare minimally invasive glucose monitoring devices with conventional monitoring in the management of insulin-treated diabetes mellitus (MITRE). Health Technology Assessment. 13(28). iii–iv, ix. 16 indexed citations
12.
Cooke, Debbie, Steven J. Hurel, Angela Casbard, et al.. (2009). Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA1c in insulin‐treated diabetes (MITRE Study). Diabetic Medicine. 26(5). 540–547. 30 indexed citations
14.
Ray, Wayne A., Jo Taylor, Patricia Gideon, et al.. (2005). Prevention of Fall-Related Injuries in Long-term Care. Archives of Internal Medicine. 165(19). 2293–2293. 50 indexed citations
15.
Hepworth, Joseph T., Natalie J. Collins, Deborah Ford, et al.. (2004). Decision-making about hormone replacement therapy by women in England and Scotland. Climacteric. 7(1). 41–49. 19 indexed citations
16.
Brown, Nancy J., Marie R. Griffin, Wayne A. Ray, et al.. (1998). A Model for Improving Medication Use in Home Health Care Patients. Journal of the American Pharmaceutical Association (1996). 38(6). 696–702. 23 indexed citations
17.
Meredith, Sarah, Judith Watson, K M Citron, Anne Cockcroft, & Janet Darbyshire. (1996). Are healthcare workers in England and Wales at increased risk of tuberculosis?. BMJ. 313(7056). 522–525. 48 indexed citations
18.
Meredith, Sarah. (1995). Surveillance systems for occupational disease. The Annals of Occupational Hygiene. 39(2). 257–260. 2 indexed citations
19.
Darbyshire, Janet, et al.. (1994). Tuberculosis in children: a national survey of notifications in England and Wales in 1988. Medical Research Council Cardiothoracic Epidemiology Group.. Archives of Disease in Childhood. 70(6). 497–500. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026